Publications

Found 97 results
Type [ Year(Asc)]
2014
E Schulz, T Bergmann, M Gebbing, V Schildgen, O Schildgen, C Gersbach, and A Ehrhardt. "Mutation Detection Following Non-Homologous End Joining (NHEJ): A Comparison of Different Semi Quantitative and Quantitative Methods." In Molecular Therapy, S126-S127. Vol. 22. 2014.
JM Brunger, NP Huynh, CM Guenther, P Perez-Pinera, FT Moutos, J Sanchez-Adams, CA Gersbach, and F Guilak. "Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage." Proceedings of the National Academy of Sciences of USA 111, no. 9 (2014): E798-E806.
AM Kabadi, and CA Gersbach. "Special issue on engineered DNA-binding proteins." ACS Synthetic Biology 3, no. 10 (2014): 702-703.
CA Gersbach, T Gaj, and CF Barbas. "Synthetic zinc finger proteins: the advent of targeted gene regulation and genome modification technologies." Accounts of Chemical Research 47, no. 8 (2014): 2309-2318.
KA Glass, JM Link, JM Brunger, FT Moutos, CA Gersbach, and F Guilak. "Tissue-engineered cartilage with inducible and tunable immunomodulatory properties." Biomaterials 35, no. 22 (2014): 5921-5931.
KA Glass, JM Link, JM Brunger, FT Moutos, CA Gersbach, and F Guilak. "Tissue-engineered cartilage with inducible and tunable immunomodulatory properties." Biomaterials 35, no. 22 (2014): 5921-5931.
S Chakraborty, H Ji, J Chen, CA Gersbach, and KW Leong. "Vector modifications to eliminate transposase expression following piggyBac-mediated transgenesis." Scientific Reports 4 (2014).
2013
CA Gersbach. "Engineered Proteins for Controlling Gene Expression." Handbook of Stem Cells 1 (2013): 125-138.
DG Ousterout, P Perez-Pinera, PI Thakore, AM Kabadi, MT Brown, X Qin, O Fédrigo, V Mouly, JP Tremblay, and CA Gersbach. "Erratum: Reading Frame correction by targeted genome editing restores dystrophin expression in cells from duchenne muscular dystrophy patients (Molecular Therapy (2013) 21 (1718-1726) DOI: 10.1038/mt.2013.111)." Molecular Therapy 21, no. 11 (2013): 2130-.
CL Duvall, A Prokop, CA Gersbach, and JM Davidson. "Gene Delivery into Cells and Tissues." (2013): 687-723.
MS Bhakta, IM Henry, DG Ousterout, KT Das, SH Lockwood, JF Meckler, MC Wallen, A Zykovich, Y Yu, H Leo et al. "Highly active zinc-finger nucleases by extended modular assembly." Genome research 23, no. 3 (2013): 530-538.
DW Dumbauld, TT Lee, A Singh, J Scrimgeour, CA Gersbach, EA Zamir, J Fu, CS Chen, JE Curtis, SW Craig et al. "How vinculin regulates force transmission." Proceedings of the National Academy of Sciences of USA 110, no. 24 (2013): 9788-9793.
DG Ousterout, P Perez-Pinera, PI Thakore, AM Kabadi, MT Brown, X Qin, O Fédrigo, V Mouly, JP Tremblay, and CA Gersbach. "Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients." Molecular Therapy 21, no. 9 (2013): 1718-1726.
P Perez-Pinera, DD Kocak, CM Vockley, AF Adler, AM Kabadi, LR Polstein, PI Thakore, KA Glass, DG Ousterout, KW Leong et al. "RNA-guided gene activation by CRISPR-Cas9-based transcription factors." Nature Methods 10, no. 10 (2013): 973-976.
TM Gibson, and CA Gersbach. "The role of single-cell analyses in understanding cell lineage commitment." Biotechnology Journal 8, no. 4 (2013): 397-407.
P Perez-Pinera, DG Ousterout, JM Brunger, AM Farin, KA Glass, F Guilak, GE Crawford, AJ Hartemink, and CA Gersbach. "Synergistic and Tunable Gene Activation by Combinations of Synthetic Transcription Factors." In Molecular Therapy, S93. Vol. 21. 2013.
P Perez-Pinera, DG Ousterout, JM Brunger, AM Farin, KA Glass, F Guilak, GE Crawford, AJ Hartemink, and CA Gersbach. "Synergistic and tunable human gene activation by combinations of synthetic transcription factors." Nature Methods 10, no. 3 (2013): 239-242.
CA Gersbach, and CFB III. "Targeted plasmid integration into the Human Genome by engineered recombinases." Topics in Current Genetics 23 (2013): 267-284.
JP Tremblay, X Xiao, A Aartsma-Rus, C Barbas, HM Blau, AJ Bogdanove, K Boycott, S Braun, XO Breakefield, JA Bueren et al. "Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases." Molecular Therapy 21, no. 2 (2013): 266-268.
KA Glass, JM Brunger, CA Gersbach, and F Guilak. "TUNABLE EXPRESSION OF IL-1RA IN GENETICALLY MODIFIED MESENCHYMAL STEM CELLS FOR CARTILAGE TISSUE ENGINEERING." In Osteoarthritis and Cartilage, S282-S283. Vol. 21. 2013.
T Gaj, CA Gersbach, and CF Barbas. "ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering." Trends in Biotechnology 31, no. 7 (2013): 397-405.
2012
P Perez-Pinera, DG Ousterout, and CA Gersbach. "Advances in targeted genome editing." Current Opinion in Chemical Biology 16, no. 3-4 (2012): 268-277.
P Perez-Pinera, DG Ousterout, MT Brown, and CA Gersbach. "Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleases." Nucleic Acids Research 40, no. 8 (2012): 3741-3752.
LR Polstein, and CA Gersbach. "Light-inducible spatiotemporal control of gene activation by customizable zinc finger transcription factors." Journal of the American Chemical Society 134, no. 40 (2012): 16480-16483.
LR Polstein, and CA Gersbach. "Photoregulated gene expression in human cells with light-inducible engineered transcription factors." ASME 2012 Summer Bioengineering Conference, SBC 2012 (2012): 351-352.

Pages